🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the manufacturers of Tylenol, alleging the firms concealed alleged dangers that the drug created to children's brain development.

This legal action arrives a month after Former President Trump publicized an unsubstantiated connection between using acetaminophen - referred to as paracetamol - throughout gestation and autism in offspring.

Paxton is suing the pharmaceutical giant, which formerly manufactured the drug, the sole analgesic suggested for pregnant women, and the current manufacturer, which now manufacturers it.

In a declaration, he said they "deceived the public by making money from discomfort and pushing pills ignoring the potential hazards."

Kenvue states there is no credible evidence tying acetaminophen to autism spectrum disorder.

"These corporations deceived for years, knowingly endangering countless individuals to line their pockets," the attorney general, a Republican, stated.

The manufacturer said in a statement that it was "very worried by the perpetuation of misinformation on the security of paracetamol and the likely effects that could have on the well-being of US mothers and children."

On its website, Kenvue also stated it had "continuously evaluated the relevant science and there is no credible data that shows a established connection between taking acetaminophen and autism."

Organizations acting on behalf of medical professionals and healthcare providers share this view.

The American College of Obstetricians and Gynecologists has stated acetaminophen - the primary component in acetaminophen - is one of the few options for pregnant women to treat pain and elevated temperature, which can create significant medical dangers if not addressed.

"In multiple decades of investigation on the use of acetaminophen in pregnancy, zero credible investigations has definitively established that the consumption of paracetamol in any trimester of pregnancy causes brain development issues in children," the association said.

The court filing references recent announcements from the Trump administration in asserting the medication is reportedly hazardous.

Recently, Trump caused concern from health experts when he advised pregnant women to "fight like hell" not to consume acetaminophen when ill.

The US Food and Drug Administration then published an announcement that physicians should think about restricting the consumption of acetaminophen, while also declaring that "a causal relationship" between the drug and autism spectrum disorder in children has remains unverified.

The Health Department head RFK Jr, who supervises the FDA, had pledged in spring to undertake "extensive scientific investigation" that would establish the source of autism spectrum disorder in a short period.

But specialists advised that discovering a sole reason of autism - believed by scientists to be the consequence of a intricate combination of genetic and surrounding conditions - would not be simple.

Autism spectrum disorder is a category of lifelong neurodivergence and condition that affects how people encounter and engage with the surroundings, and is recognized using physician assessments.

In his legal document, the attorney general - who supports Trump who is campaigning for federal office - asserts Kenvue and Johnson & Johnson "deliberately disregarded and attempted to silence the science" around acetaminophen and autism spectrum disorder.

This legal action aims to force the firms "eliminate any marketing or advertising" that states acetaminophen is reliable for pregnant women.

This legal action echoes the complaints of a collection of guardians of young ones with autism and ADHD who filed suit against the makers of Tylenol in two years ago.

A federal judge rejected the lawsuit, saying studies from the parents' expert witnesses was inconclusive.